Making the move to AAV producer cell lines: comparability, bridging studies and regulatory considerations
Cell and Gene Therapy Insights 2026; 12(9)
10.18609/cgti.2026.114
Published: 17 November
Podcast
Lauren Coyle (Editor, BioInsights) speaks with Lonza's Laura Sands (Head of Regulatory Affairs), Ramesh Koukuntla (Director of R&D), Wenling Dong (Head of Upstream Process Development), and Vijetha Bhat (Subject Expert of Platform Technologies) about:
✓
Key regulatory considerations when transitioning to AAV producer cell lines
✓
Comparability and bridging strategies to support a successful transition
✓
Approaches to managing manufacturing and regulatory risk
✓
Considerations for enabling scalable AAV production
Follow the Podcast to make sure you don't miss the next episode.
Listen to the podcast here.
If you enjoyed this episode, you can listen to all episodes from The BioInsights Podcast wherever you normally get your podcasts.
